Clozapine
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00363 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | manic bipolar affective disorder | KG + DL |
| 2 | Tourette syndrome | KG + DL |
| 3 | trichotillomania | KG + DL |
| 4 | schizophreniform disorder | KG + DL |
| 5 | bipolar disorder | KG + DL |
| 6 | major affective disorder | KG + DL |
| 7 | attention deficit-hyperactivity disorder | KG + DL |
| 8 | attention deficit hyperactivity disorder, inattentive type | KG + DL |
| 9 | psychotic disorder | KG + DL |
| 10 | Malan overgrowth syndrome | KG + DL |
| 11 | obsessive-compulsive disorder | KG + DL |
| 12 | mental disorder | KG + DL |
| 13 | distal 17p13.3 microdeletion syndrome | KG + DL |
| 14 | faciodigitogenital syndrome | KG + DL |
| 15 | chondromyxoid fibroma | KG + DL |
| 16 | myofascial pain syndrome | KG + DL |
| 17 | treatment-refractory schizophrenia | KG + DL |
| 18 | anxiety disorder | KG + DL |
| 19 | nicotine dependence | KG + DL |
| 20 | early-onset schizophrenia | KG + DL |
| 21 | specific developmental disorder | KG + DL |
| 22 | REM sleep behavior disorder | KG + DL |
| 23 | dysthymic disorder | KG + DL |
| 24 | schizophrenia | KG + DL |
| 25 | psychosexual disorder | KG + DL |
| 26 | schizotypal personality disorder | KG + DL |
| 27 | schizoid personality disorder | KG + DL |
| 28 | paranoid personality disorder | KG + DL |
| 29 | histrionic personality disorder (disease) | KG + DL |
| 30 | idiopathic granulomatous myositis | KG + DL |
| 31 | myositis fibrosa | KG + DL |
| 32 | 46,XY disorder of sex development due to testicular steroidogenesis defect | KG + DL |
| 33 | fibromyalgia | KG + DL |
| 34 | tendinitis | KG + DL |
| 35 | hydrops-lactic acidosis-sideroblastic anemia-multisystemic failure syndrome | KG + DL |
| 36 | transverse vaginal septum | KG + DL |
| 37 | longitudinal vaginal septum | KG + DL |
| 38 | schizoaffective disorder | KG + DL |
| 39 | benign paroxysmal torticollis of infancy | KG + DL |
| 40 | skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome | KG + DL |
| 41 | enuresis | KG + DL |
| 42 | visual epilepsy | KG + DL |
| 43 | trigeminal nerve neoplasm | KG + DL |
| 44 | dissociative disorder | KG + DL |
| 45 | neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal recessive | KG + DL |
| 46 | factitious disorder | KG + DL |
| 47 | agoraphobia | KG + DL |
| 48 | migraine disorder | KG + DL |
| 49 | progressive supranuclear palsy | KG + DL |
| 50 | mixed anxiety and depressive disorder | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.